Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510060, China
NCT Number: NCT03023800
Macular schisis associated with macular detachment is a one of the complications of high myopia. There is controversy in the primary treatment for this situation. This study will compare the effects of macular buckling + gas injection versus vitrectomy + internal limiting membrane peeling + gas tamponade in a cohort of highly myopic eyes with macular retinal detachment associated with macular schisis.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510060, China
A randomized, open label, single center study comparing the efficacy of macular muckle + gas injection versus internal limiting membrane peeling + gas tamponade on macular schisis associated with macular detachment in eyes with high myopia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical procedures of macular buckling, drainage of aqueous fluid (0.1-0.2 ml) through limbal paracentesis, and inject gas ( C3F8 100%, 0.2ml-0.3ml) into vitreous body through pars plana, under systemic anesthesia.
Surgical procedures of small gauge vitrectomy, internal limiting membrane peeling, and gas (C3F8, 14%) tamponage, under local or systemic anesthesia
Time frame: 3 month
Time frame: 12 month
Time frame: 12 month
Sun Yat-sen University
Other
A Randomized, Open Label, Single Center Study Comparing the Efficacy of Macular Buckle Versus Vitrectomy + Internal Limiting Membrane Peeling + Gas Tamponade on Macular Schisis and Concurrent Macular Detachment in Eyes With Highly Myopia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00055029
Eye Diseases, Macular Degeneration
Bethesda, Maryland, United States
View Trial DetailsNCT06114537
Eye Diseases, Retinal Degeneration
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT02317887
Eye Diseases, Retinal Degeneration
Bethesda, Maryland, United States
View Trial DetailsNCT02317354
Eye Diseases, Retinal Degeneration
Bethesda, Maryland, United States
View Trial Details